NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)

Journal of Virology

Volumn 84, Issue 24, 2010, Pages 12733-12753

  Sharma Walia, Neelam ^a   Paul, Arun George ^a   Patel, Kinjan ^a   Chandran, Karthic ^a   Ahmad, Waseem ^a   Chandran, Bala ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CIS ACTING ELEMENT; CRE RECOMBINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYCLOSPORIN A; FOCAL ADHESION KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; SERINE; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME REGULATION; GENE DELETION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS PATHOGENESIS;

BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; DERMIS; DINOPROSTONE; DNA, VIRAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

HUMAN HERPESVIRUS 8;

EID: 78649439518     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01065-10     Document Type: Article

References (79)

1. 2 in mouse skin. Carcinogenesis 28:2063-2068.
2. Aramburu, J., M. B. Yaffe, C. Lopez-Rodriguez, L. C. Cantley, P. G. Hogan, and A. Rao. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133. (Pubitemid 29451431)
3. 2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J. Biol. Chem. 280:29993-30000.
4. Buchanan, F. G., and R. N. DuBois. 2006. Connecting COX-2 and Wnt in cancer. Cancer Cell 9:6-8.
5. Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
6. 2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling. Mol. Cell. Biol. 26:8281-8292.
7. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
8. Crofford, L. J., R. L. Wilder, A. P. Ristimaki, H. Sano, E. F. Remmers, H. R. Epps, and T. Hla. 1994. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93:1095-1101.
9. Degousee, N., J. Martindale, E. Stefanski, M. Cieslak, T. F. Lindsay, J. E. Fish, P. A. Marsden, D. J. Thuerauf, C. C. Glembotski, and B. B. Rubin. 2003. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ. Res. 92:757-764.
10. Dubois, R. N. 2000. Review article: cyclooxygenase - a target for colon cancer prevention. Aliment. Pharmacol. Ther. 14(Suppl. 1):64-67.
11. Dubois, R. N., S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. Van De Putte, and P. E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12:1063-1073.
12. Fang, X., S. X. Yu, Y. Lu, R. C. Bast, Jr., J. R. Woodgett, and G. B. Mills. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. U. S. A. 97:11960-11965.
13. Feske, S., H. Okamura, P. G. Hogan, and A. Rao. 2003. Ca2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311:1117-1132.
14. 2. Prostaglandins 19:917-931.
15. Fletcher, B. S., D. A. Kujubu, D. M. Perrin, and H. R. Herschman. 1992. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:4338-4344.
16. 2 activates Stat3 in neonatal rat ventricular cardiomyocytes: a role in cardiac hypertrophy. Cardiovasc. Res. 73:57-65.
17. Fujimuro, M., F. Y. Wu, C. ApRhys, H. Kajumbula, D. B. Young, G. S. Hayward, and S. D. Hayward. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9:300-306.
18. 2 dependent cell survival through the PI3 kinase/AKT pathway. Prostaglandins Other Lipid Mediat. 83:112-120.
19. 2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen. Cancer Res. 70:3697-3708.
20. Harper, K. A., and A. J. Tyson-Capper. 2008. Complexity of COX-2 gene regulation. Biochem. Soc Trans. 36:543-545.
21. Hierholzer, C., B. G. Harbrecht, T. R. Billiar, and D. J. Tweardy. 2001. Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Arch. Orthop. Trauma Surg. 121:219-222.
22. Hla, T., and K. Neilson. 1992. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U. S. A. 89:7384-7388.
23. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232.
24. Howe, L. R., H. C. Crawford, K. Subbaramaiah, J. A. Hassell, A. J. Dannenberg, and A. M. Brown. 2001. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J. Biol. Chem. 276:20108-20115.
25. Iñiguez, M. A., S. Martinez-Martinez, C. Punzon, J. M. Redondo, and M. Fresno. 2000. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275:23627-23635.
26. Iñiguez, M. A., C. Punzon, and M. Fresno. 1999. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase- 2 inhibitors. J. Immunol. 163:111-119.
27. 2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res. 64:7439-7446.
28. Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352-355. (Pubitemid 23288978)
29. Jung, Y. J., J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers. 2003. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17:2115-2117.
30. Kobayashi, M., and K. Kawakami. 1995. ATF-1CREB heterodimer is involved in constitutive expression of the housekeeping Na,K-ATPase alpha 1 subunit gene. Nucleic Acids Res. 23:2848-2855.
31. Krishnan, H. H., P. P. Naranatt, M. S. Smith, L. Zeng, C. Bloomer, and B. Chandran. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620.
32. 2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in nonsmall cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 65:6275-6281.
33. 2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res. 68:553-560.
34. Lin, D. T., K. Subbaramaiah, J. P. Shah, A. J. Dannenberg, and J. O. Boyle. 2002. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792-799.
35. 2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 277:50081-50086.
36. Loh, C., K. T. Shaw, J. Carew, J. P. Viola, C. Luo, B. A. Perrino, and A. Rao. 1996. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J. Biol. Chem. 271:10884-10891.
37. 2 induction of binding activity to CRE and AP-2 elements in human T lymphocytes. Cell. Immunol. 174:99-105.
38. 2 activates Ca2+ channels in bovine adrenal chromaffin cells. J. Neurochem. 56:541-547.
39. Montminy, M., P. Brindle, J. Arias, K. Ferreri, and R. Armstrong. 1996. Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism 45(8 Suppl. 1):4-7.
40. Murphy, P. M. 1997. Pirated genes in Kaposi's sarcoma. Nature 385:296-297, 299.
41. Nabors, L. B., G. Y. Gillespie, L. Harkins, and P. H. King. 2001. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61:2154-2161.
42. Naranatt, P. P., S. M. Akula, C. A. Zien, H. H. Krishnan, and B. Chandran. 2003. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J. Virol. 77:1524-1539.
43. Naranatt, P. P., H. H. Krishnan, S. R. Svojanovsky, C. Bloomer, S. Mathur, and B. Chandran. 2004. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 64:72-84.
44. Okamura, H., J. Aramburu, C. Garcia-Rodriguez, J. P. Viola, A. Raghavan, M. Tahiliani, X. Zhang, J. Qin, P. G. Hogan, and A. Rao. 2000. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 6:539-550.
45. Park, J., N. R. Yaseen, P. G. Hogan, A. Rao, and S. Sharma. 1995. Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J. Biol. Chem. 270:20653-20659.
46. Pham, L., O. Bezouglaia, P. M. Camargo, J. M. Nervina, and S. Tetradis. 2007. Prostanoids induce egr1 gene expression in cementoblastic OCCM cells. J. Periodontal Res. 42:486-493.
47. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
48. Ridley, S. H., J. L. Dean, S. J. Sarsfield, M. Brook, A. R. Clark, and J. Saklatvala. 1998. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:75-80.
49. Ristimaki, A., S. Garfinkel, J. Wessendorf, T. Maciag, and T. Hla. 1994. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J. Biol. Chem. 269:11769-11775.
50. Rosenberg, D., L. Groussin, E. Jullian, K. Perlemoine, X. Bertagna, and J. Bertherat. 2002. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann. N. Y. Acad. Sci. 968:65-74.
51. Sadagopan, S., N. Sharma-Walia, M. V. Veettil, H. Raghu, R. Sivakumar, V. Bottero, and B. Chandran. 2007. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol. 81:3949-3968. (Pubitemid 46586891)
52. 2 activates HPK1 kinase activity via a PKA-dependent pathway. J. Biol. Chem. 282:34693-34699.
53. Sharma-Walia, N., H. H. Krishnan, P. P. Naranatt, L. Zeng, M. S. Smith, and B. Chandran. 2005. ERK1/2 and MEK1/2 induced by Kaposi's sarcomaassociated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79:10308-10329. (Pubitemid 41098572)
54. Sharma-Walia, N., P. P. Naranatt, H. H. Krishnan, L. Zeng, and B. Chandran. 2004. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J. Virol. 78:4207-4223. (Pubitemid 38437226)
55. Sharma-Walia, N., A. G. Paul, V. Bottero, S. Sadagopan, M. V. Veettil, N. Kerur, and B. Chandran. 2010. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog. 6:e1000777.
56. Sharma-Walia, N., H. Raghu, S. Sadagopan, R. Sivakumar, M. V. Veettil, P. P. Naranatt, M. M. Smith, and B. Chandran. 2006. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J. Virol. 80:6534-6552. (Pubitemid 43927455)
57. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
58. Shaw, K. T., A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P. G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. U. S. A. 92:11205-11209.
59. Shaywitz, A. J., and M. E. Greenberg. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-861.
60. Shelby, B. D., A. Nelson, and C. Morris. 2005. Gamma-herpesvirus neoplasia: a growing role for COX-2. Microsc. Res. Tech. 68:120-129.
61. Shibasaki, F., E. R. Price, D. Milan, and F. McKeon. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370-373. (Pubitemid 26260467)
62. Sirois, J., and J. S. Richards. 1993. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP beta promoter element. J. Biol. Chem. 268:21931-21938.
63. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-182.
64. Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, and A. T. Haase. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
65. Steer, S. A., J. M. Moran, B. S. Christmann, L. B. Maggi, Jr., and J. A. Corbett. 2006. Role of MAPK in the regulation of double-stranded RNA-and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. J. Immunol. 177:3413-3420.
66. Streicher, J. M., S. Ren, H. Herschman, and Y. Wang. 2010. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 106:1434-1443.
67. Subbaramaiah, K., J. C. Hart, L. Norton, and A. J. Dannenberg. 2000. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275:14838-14845.
68. Tamura, M., S. Sebastian, B. Gurates, S. Yang, Z. Fang, and S. E. Bulun. 2002. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J. Clin. Endocrinol. Metab. 87:3504-3507.
69. Taylor, S. S., C. Kim, C. Y. Cheng, S. H. Brown, J. Wu, and N. Kannan. 2008. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim. Biophys. Acta 1784:16-26.
70. Veettil, M. V., S. Sadagopan, N. Sharma-Walia, F. Z. Wang, H. Raghu, L. Varga, and B. Chandran. 2008. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J. Virol. 82:12126-12144.
71. Veettil, M. V., N. Sharma-Walia, S. Sadagopan, H. Raghu, R. Sivakumar, P. P. Naranatt, and B. Chandran. 2006. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J. Virol. 80:11432-11446. (Pubitemid 44788859)
72. Vieira, J., M. L. Huang, D. M. Koelle, and L. Corey. 1997. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J. Virol. 71:7083-7087. (Pubitemid 27355375)
73. 2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol. Carcinog. 46:912-923.
74. Wu, G., A. P. Mannam, J. Wu, S. Kirbis, J. L. Shie, C. Chen, R. J. Laham, F. W. Sellke, and J. Li. 2003. Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. Am. J. Physiol. Heart Circ. Physiol. 285:H2420-H2429.
75. Wu, W., R. A. Silbajoris, Y. E. Whang, L. M. Graves, P. A. Bromberg, and J. M. Samet. 2005. p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L883-L889.
76. Xie, W., J. R. Merrill, W. S. Bradshaw, and D. L. Simmons. 1993. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch. Biochem. Biophys. 300:247-252.
77. 2 activates Src signaling in lung adenocarcinoma cell via EP3. Cancer Lett. 214:115-120.
78. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. U. S. A. 93:6641-6646.
79. Zoeteweij, J. P., A. V. Moses, A. S. Rinderknecht, D. A. Davis, W. W. Overwijk, R. Yarchoan, J. M. Orenstein, and A. Blauvelt. 2001. Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. Blood 97:2374-2380.